PHARMATHENE, INC

Biotechnology research, development and manufacturing. Biodefense vaccines/therapeutics

Filings
43
Clients
1
Total Income
Years Active
2007–2016

Filings

Year Client Period Income Expenses Doc
2016 PHARMATHENE, INC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Termination (No Activity)
2015 PHARMATHENE, INC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report (No Activity)
2015 PHARMATHENE, INC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report (No Activity)
2015 PHARMATHENE, INC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Termination (No Activity)
2014 PHARMATHENE, INC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$10,000
2014 PHARMATHENE, INC 3rd Quarter (July 1 - Sep 30)
AMENDED
2014 PHARMATHENE, INC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
2014 PHARMATHENE, INC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$53,000
2014 PHARMATHENE, INC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$84,512
2013 PHARMATHENE, INC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$76,358
Page 1 of 5  ·  43 filings Next

Clients Represented

ClientFilingsTotal Income
PHARMATHENE, INC 43

Lobbyists

NameDisclosed Prior Position
FRANCESCA COOK VP, POLICY & GOVERNMENT AFFAIRS
MARK EDWARD COOKE SR. DIRECTOR, GOVERNMENT AFFAIRS